These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32618696)

  • 21. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
    Schulman S
    Semin Thromb Hemost; 2020 Oct; 46(7):772-776. PubMed ID: 32392613
    [No Abstract]   [Full Text] [Related]  

  • 22. SARS-CoV-2 and Stroke in a New York Healthcare System.
    Yaghi S; Ishida K; Torres J; Mac Grory B; Raz E; Humbert K; Henninger N; Trivedi T; Lillemoe K; Alam S; Sanger M; Kim S; Scher E; Dehkharghani S; Wachs M; Tanweer O; Volpicelli F; Bosworth B; Lord A; Frontera J
    Stroke; 2020 Jul; 51(7):2002-2011. PubMed ID: 32432996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of venous thromboembolism in hospitalized patients with COVID-19.
    Middeldorp S; Coppens M; van Haaps TF; Foppen M; Vlaar AP; Müller MCA; Bouman CCS; Beenen LFM; Kootte RS; Heijmans J; Smits LP; Bonta PI; van Es N
    J Thromb Haemost; 2020 Aug; 18(8):1995-2002. PubMed ID: 32369666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill.
    Mortus JR; Manek SE; Brubaker LS; Loor M; Cruz MA; Trautner BW; Rosengart TK
    JAMA Netw Open; 2020 Jun; 3(6):e2011192. PubMed ID: 32501489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex and prolonged hypercoagulability in coronavirus disease 2019 intensive care unit patients: A thromboelastographic study.
    Cordier PY; Pierrou C; Noel A; Paris R; Gaudray E; Martin E; Contargyris C; Bélot-De Saint Léger F; Lyochon A; Astier H; Desmots F; Savini H; Surcouf C
    Aust Crit Care; 2021 Mar; 34(2):160-166. PubMed ID: 33509706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coagulopathy of Coronavirus Disease 2019.
    Iba T; Levy JH; Levi M; Connors JM; Thachil J
    Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both.
    Levi M; Thachil J
    Semin Thromb Hemost; 2020 Oct; 46(7):781-784. PubMed ID: 32512589
    [No Abstract]   [Full Text] [Related]  

  • 28. Thromboelastography Parameters and Platelet Count on Admission to the ICU and the Development of Venous Thromboembolism in Patients With Coronavirus Disease 2019.
    Marvi TK; Stubblefield WB; Tillman BF; Tenforde MW; Feldstein LR; Patel MM; Self WH; Grijalva CG; Rice TW
    Crit Care Explor; 2021 Mar; 3(3):e0354. PubMed ID: 33786433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states.
    Thachil J
    J Thromb Haemost; 2020 Aug; 18(8):1849-1852. PubMed ID: 32588535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19.
    Berger JS; Kunichoff D; Adhikari S; Ahuja T; Amoroso N; Aphinyanaphongs Y; Cao M; Goldenberg R; Hindenburg A; Horowitz J; Parnia S; Petrilli C; Reynolds H; Simon E; Slater J; Yaghi S; Yuriditsky E; Hochman J; Horwitz LI
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2539-2547. PubMed ID: 32840379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
    Al-Samkari H; Karp Leaf RS; Dzik WH; Carlson JCT; Fogerty AE; Waheed A; Goodarzi K; Bendapudi PK; Bornikova L; Gupta S; Leaf DE; Kuter DJ; Rosovsky RP
    Blood; 2020 Jul; 136(4):489-500. PubMed ID: 32492712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019.
    Creel-Bulos C; Liu M; Auld SC; Gaddh M; Kempton CL; Sharifpour M; Sniecinski RM; Maier CL; Nahab FB; Rangaraju S
    Medicine (Baltimore); 2020 Nov; 99(46):e23186. PubMed ID: 33181697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
    Cummings MJ; Baldwin MR; Abrams D; Jacobson SD; Meyer BJ; Balough EM; Aaron JG; Claassen J; Rabbani LE; Hastie J; Hochman BR; Salazar-Schicchi J; Yip NH; Brodie D; O'Donnell MR
    Lancet; 2020 Jun; 395(10239):1763-1770. PubMed ID: 32442528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronavirus Disease 2019: Hematological Anomalies and Antithrombotic Therapy.
    Ornelas-Ricardo D; Jaloma-Cruz AR
    Tohoku J Exp Med; 2020 Aug; 251(4):327-336. PubMed ID: 32788506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer.
    Rodriguez-Sevilla JJ; Rodó-Pin A; Espallargas I; Villar-García J; Molina L; Pérez Terán P; Vázquez Sanchez A; Masclans JR; Jiménez C; Millan Segovia R; Zuccarino F; Salar A; Rodriguez-Chiaradía DA
    Arch Bronconeumol (Engl Ed); 2020 Nov; 56(11):758-759. PubMed ID: 32773301
    [No Abstract]   [Full Text] [Related]  

  • 38. Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis.
    Sakka M; Connors JM; Hékimian G; Martin-Toutain I; Crichi B; Colmegna I; Bonnefont-Rousselot D; Farge D; Frere C
    J Med Vasc; 2020 Sep; 45(5):268-274. PubMed ID: 32862984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications.
    Voicu S; Delrue M; Chousterman BG; Stépanian A; Bonnin P; Malissin I; Deye N; Neuwirth M; Ketfi C; Mebazaa A; Siguret V; Mégarbane B
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9161-9168. PubMed ID: 32965009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.
    Ramacciotti E; Macedo AS; Biagioni RB; Caffaro RA; Lopes RD; Guerra JC; Orsi FA; Marques MA; Tafur AJ; Caprini JA; Nicolaides A; Carter CA; Filho CC; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936350. PubMed ID: 32649232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.